Aashka Hospitals Ltd (AASHKA) — shareholding pattern, promoter holding, financials and share price
About Aashka Hospitals Ltd (AASHKA)
Aashka Hospitals Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as AASHKA and on the BSE under scrip code 543346. Its ISIN is INE0EAX01014.
Incorporated in 2012, Aashka Hospitals Ltd operates Multi Disciplinary Private Hospital, Clinics, and Pharmacies [1]
Aashka Hospitals Limited is an integrated healthcare service provider offering a wide range of healthcare services, including critical care, pediatrics, surgery, cardiology, and neurology, among others, primarily to patients in Gujarat, India.
Founded in 2015 by Bipinchandra Shah, the company aims to provide high-quality healthcare facilities in Gujarat, leveraging modern technologies and state-of-the-art facilities.
Listed peers in Hospital: Hannah Joseph Hospital Ltd, Lotus Eye Hospital & Institute Ltd, Abate As Industries Ltd, Fortis Malar Hospitals Ltd, Maitreya Medicare Ltd, Shanmuga Hospital Ltd.
Valuation & Returns
At ₹81.9 a share, Aashka Hospitals Ltd (AASHKA) was valued at a price-to-earnings ratio of 57.38x against an industry P/E of 61.73x and a price-to-book of 1.86x on a book value of ₹44.13 per share. Solomo computes return on equity of 2.75% and return on capital employed of 4.05% from filed results.
- P/E
- 57.38x
- Industry P/E
- 61.73x
- P/B
- 1.86x
- EPS (TTM)
- ₹1.4
- Book value / share
- ₹44.13
- ROE
- 2.75%
- ROCE
- 4.05%
- ROA
- 2.88%
- Debt / equity
- 0.08x
- Dividend yield
- 0%
- EBITDA margin
- 35.25%
- 52-week range
- ₹59 – ₹103
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Aashka Hospitals Ltd (AASHKA) reported revenue of ₹23.01 crore, net profit of ₹3.34 crore and earnings per share of ₹1.43. That compares with revenue of ₹22.65 crore and net profit of ₹3.27 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹12.57 crore and net profit ₹2.56 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 39.73 | 18.94 | 22.87 | 22.65 | 23.01 |
| Net profit (₹ cr) | 2.37 | -2.57 | 2.36 | 3.27 | 3.34 |
| EPS (₹) | 1.01 | -1.1 | 1.01 | 1.4 | 1.43 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | -3.62% | -17.09% | -0.96% |
| Profit growth | 18.82% | 11.36% | 38.56% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 61.33% of Aashka Hospitals Ltd (AASHKA). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2021.
Largest disclosed public shareholders in Mar 2026: MOHIT PRAKASH JALAN 2.38%, DHARMESH MALDEVBHAI GODHANIA 2.11%, RAJRADHE FINANCE LIMITED 1.98%, VIJAYKUMAR MALDEVBHAI GODHANIA 1.64%, DEVAL ROHITBHAI SHAH 1.46%, VIRAL MUKUNDCHANDRA SHAH 1.22%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 61.33% | - | - | - | 38.67% |
| Sep 2025 | 61.33% | - | - | - | 38.67% |
| Mar 2025 | 61.28% | - | - | - | 38.72% |
| Sep 2024 | 61.28% | - | - | - | 38.72% |
| Mar 2024 | 61.28% | - | - | - | 38.72% |
| Sep 2023 | 61.28% | - | - | - | 38.72% |
| Mar 2023 | 61.28% | - | - | - | 38.72% |
| Sep 2022 | 61.28% | - | - | - | 38.72% |